Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Kalvin C. Yu"'
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Infections caused by multi-drug resistant Gram-negative pathogens are associated with worse clinical outcomes in critically ill patients. We evaluated hospital outcomes based on adequacy of overall and newer antibacterial therapy
Externí odkaz:
https://doaj.org/article/44c58710241b45c59df79ccc2b4eac64
Publikováno v:
International Journal of Infectious Diseases, Vol 143, Iss , Pp 107023- (2024)
ABSTRACT: Objectives: To evaluate the clinical and economic outcomes in adults hospitalized with invasive pneumococcal disease (IPD) and noninvasive all-cause pneumonia (ACP) overall and by antimicrobial resistance (AMR) status. Methods: Hospitalized
Externí odkaz:
https://doaj.org/article/ff12dbc583b44d919254d0af9d183803
Autor:
Karri A. Bauer, Laura A. Puzniak, Kalvin C. Yu, Kenneth P. Klinker, Janet A. Watts, Pamela A. Moise, Lyn Finelli, Vikas Gupta
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Antibiotic usage and antibiotic resistance (ABR) patterns changed during the COVID-19 pandemic. Inadequate empiric antibiotic therapy (IET) is a significant public health problem and contributes to ABR. We evaluated factors associ
Externí odkaz:
https://doaj.org/article/bd79a4f4ac744a1ab3a466f90d277b7c
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 4 (2024)
Abstract Background: We investigated trends in Staphylococcus aureus (staph) bacteremia incidence stratified by methicillin susceptibility (methicillin-susceptible S. aureus [MSSA] vs. methicillin-resistant S. aureus [MRSA]) and onset designation (c
Externí odkaz:
https://doaj.org/article/64c119726c25467b8191b05c500e80b8
Autor:
Todd Riccobene, ChinEn Ai, Kalvin C. Yu, Sara Gregory, Brooke Kim, Dmitri Debabov, Vikas Gupta
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT New antibiotics have been developed to combat antibiotic-resistant Gram-negative pathogens, which are difficult to treat and associated with poor clinical outcomes. We conducted a multicenter evaluation of real-world testing practices and su
Externí odkaz:
https://doaj.org/article/2cf99efcbf7e42658bdb3539d7a6284f
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Excessive use of antibiotics has been reported during the SARS-CoV-2 pandemic. We evaluated trends in antibiotic use and culture positive Gram-negative (GN)/Gram-positive (GP) pathogens in US hospitalized patients before and durin
Externí odkaz:
https://doaj.org/article/dc22b52b6dfd4b6980821c8ba0468179
Autor:
Karri A. Bauer, Laura A. Puzniak, Kalvin C. Yu, Lyn Finelli, Pamela Moise, ChinEn Ai, Janet A. Watts, Vikas Gupta
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Bloodstream infections (BSIs) are an important cause of morbidity and mortality in hospitalized patients. We evaluate incidence of community- and hospital-onset BSI rates and outcomes before and during the SARS-CoV-2 pandemic. Met
Externí odkaz:
https://doaj.org/article/7d707de5abbc43ccaf55dccc20eb8795
Publikováno v:
International Journal of Infectious Diseases, Vol 119, Iss , Pp 142-145 (2022)
[Abstract]: Antimicrobial resistance (AMR) can complicate effective management of urinary tract infections. We conducted a retrospective study of AMR in Enterobacterales urine isolates from ambulatory and hospitalized adult patients from 2018-2020 (B
Externí odkaz:
https://doaj.org/article/8f5156fb92ef4f2884574678552b298d
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Urinary tract infections (UTIs), which are usually caused by bacteria in the Enterobacterales family, are a common reason for outpatient visits. Appropriate empiric therapy for UTIs requires an understanding of antibiotic resistan
Externí odkaz:
https://doaj.org/article/bbad54ff117a43b28da0e0764ff129e7
Autor:
Fanny S Mitrani-Gold, Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, Barbara W Trautner, Nicole E Scangarella-Oman, Kalvin C Yu, Gang Ye, Ashish V Joshi
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0285427 (2023)
BackgroundIncreasing prevalence of antimicrobial resistance (AMR), including multidrug resistance (MDR), among Escherichia coli (E. coli) makes treatment of uncomplicated urinary tract infection (uUTI) difficult. We assessed risk factors for fluoroqu
Externí odkaz:
https://doaj.org/article/af446e761b8446f7b1bfed9dd42af206